Symbol="OVID"
AssetType="Common Stock"
Name="Ovid Therapeutics Inc"
Description="Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medications for patients and families with neurological disorders in the United States. The company is headquartered in New York, New York."
CIK="1636651"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1460 BROADWAY, SUITE 15044, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="239772000"
EBITDA="-53590012"
PERatio="None"
PEGRatio="0"
BookValue="1.716"
DividendPerShare="0"
DividendYield="0"
EPS="-0.74"
RevenuePerShareTTM="0.002"
ProfitMargin="0"
OperatingMarginTTM="-438.5"
ReturnOnAssetsTTM="-0.203"
ReturnOnEquityTTM="-0.36"
RevenueTTM="123540"
GrossProfitTTM="1502700"
DilutedEPSTTM="-0.74"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.954"
AnalystTargetPrice="5.67"
TrailingPE="-"
ForwardPE="1.792"
PriceToSalesRatioTTM="87.09"
PriceToBookRatio="0.903"
EVToRevenue="4.56"
EVToEBITDA="-0.0966"
Beta="1.072"
num_52WeekHigh="3.98"
num_52WeekLow="1.405"
num_50DayMovingAverage="3.551"
num_200DayMovingAverage="2.477"
SharesOutstanding="70521000"
DividendDate="None"
ExDividendDate="None"
symbol="OVID"
open="3.46"
high="3.47"
low="3.37"
price="3.40"
volume="339927.00"
latest_trading_day="2023-07-07"
previous_close="3.45"
change="-0.05"
change_percent="-1.4493%"
aroon_positive_momentum_days="100"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="100"
Volume_recent_avg="204723"
Change_recent_avg="0.02"
Delta_recent_avg="0.19"
Variance_recent_avg="0.09"
Change_ratio_recent_avg="0.73"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="100"
Aroon_momentum_negative="0"
image_negative_thumbnail_id_1="1092"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0125.jpeg"
image_negative_thumbnail_id_2="519"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0086.jpeg"
image_neutral_thumbnail_id_1="523"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0076.jpeg"
image_neutral_thumbnail_id_2="597"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0002.jpeg"
image_positive_thumbnail_id_1="617"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0091.jpeg"
image_positive_thumbnail_id_2="1015"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0177.jpeg"
image_professor_thumbnail_id_1="1196"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
